Key result
Elevated P-wave dispersion accurately identifies idiopathic PAH with an AUC of ~0.94.
Why the study?
The study aimed to measure P-wave dispersion in the ECG of patients with pulmonary arterial hypertension.
Does P-wave dispersion on ECG correlate with the diagnosis, severity, and risk stratification of pulmonary arterial hypertension?
Observational (n=163)
No
Does P-wave dispersion on ECG correlate with the diagnosis, severity, and risk stratification of pulmonary arterial hypertension?
Absolute Event Rate: 51.24% vs 33.06%
p-value: p=<0.05
Suggests P-wave dispersion could aid noninvasive IPAH detection on ECG; leaves open validation for severity and risk stratification.
Objectives : The aim of this study was to measure the P-wave dispersion(PWD) in the ECG of patients with pulmonary arterial hypertension(PAH). Methods : A total of 103 PAH patients were collected, including 55 patients related with CHD and 44 patients with IPAH. In addition, 30 CHD patients without PAH (nPAH-CHD group) and 30 healthy controls (HCG group) were collected as control. Patients in the PAH group were categorized into the low-risk group (30 cases), moderate-risk group (53 cases) and high-risk group (20 cases), followed by comparison of PWD difference between groups. The ROC curve was used to evaluate the diagnostic efficacy of PWD on PAH-CHD and IPAH. Results : The levels of PWD and Pmax in PAH-CHD and IPAH group were significantly higher than those in nPAH-CHD and HCG group (P<0.05). PWD level was positively correlated with RVD, RAS, mPAP, PVR (r=0.407, 0.470, 0.477, 0.423, P<0.001), and was negatively correlated with TAPSE level (r =-0.551, P<0.001). After risk quantification in 103 PAH patients, we found that PWD was significantly different among the low-risk, moderate-risk and high-risk groups (43.89 ± 9.91 vs. 51.29 ± 6.61, 62.15 ± 10.44, P<0.001). CHD-PAH and IPAH were identified by PWD with a cut off value of 41.5ms (P< 0.001), and a cut off value of 41.45ms (P< 0.001), respectively. Conclusion : PWD might be an effective ECG indicator for PAH, which might be used as a relatively economical and easily accessible indicator for PAH patients to assist in early diagnosis, disease severity assessment and prognosis evaluation.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2022) conducted an observational in Pulmonary arterial hypertension (n=163). P-wave dispersion (PWD) measurement vs. Healthy controls and CHD patients without PAH was evaluated on P-wave dispersion (PWD) duration (p=<0.05). P-wave dispersion was significantly elevated in patients with pulmonary arterial hypertension compared to healthy controls and accurately identified idiopathic PAH with an AUC of 0.939.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: